Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
EHC 2022
AES 2022
WSC 2022
ECTRIMS 2022
EHDN 2022
MDS 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Stephen Salloway
3:00
Important considerations for APOE disclosure in AD risk assessment
Stephen Salloway
• 10 Mar 2021
1:39
Barriers to major advances in the Alzheimer’s field
Stephen Salloway
• 10 Mar 2021
2:53
Progress in Alzheimer’s disease: aducanumab, imaging, and blood biomarkers
Stephen Salloway
• 10 Mar 2021
1:46
Online registries allow rapid recruitment of diverse populations for AD trials
Stephen Salloway
• 10 Mar 2021